Human Longevity has successfully completed its second Series B financing round, raising $39.8 million. This follows a significant $220 million seed round that took place in May 2024, indicating strong investor interest in the company's potential. The seed round has sparked discussions about which major tech companies may be involved, particularly given the background of some team members who previously worked at Google.